← All stocks

Intuitive Surgical

ISRG Scheduled selling only
CIK 0001035267 #260 in the set updated 17 Sep 2026
Bought (12 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$93.25M
$12.30M on a plan · $80.95M straight out of an exercise
Sold at will
$0.00
0 of 82 sales
Net
−$93.25M
$0.00 against sales at will

By person

22 insiders · 82 transactions
107×

David J. Rosa holds 107 times base salary in stock. $92.43M of shares against $858.75K in salary for 2025.

Salary from the company's own proxy. The shares are what David J. Rosa last reported holding, valued at $374.44, the price Common Stock was last bought or sold at on the open market here, on 15 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
GUTHART GARY S
Director
$48.79M (8) scheduled
−$48.79M
1,269,468
0.3593%
$475.34M
+1.7%
Rosa David J.
Chief Executive Officer (CEO)
$13.41M (1) scheduled
−$13.41M
246,856
0.0699%
$92.43M
+14.3%
Curet Myriam
EVP & Chief Medical Officer
$8.44M (16) scheduled
−$8.44M
409
0.0001%
$153.15K
0.0%
Charlton Henry L
EVP & Chief Commercial and Mkt
$7.96M (5) scheduled
−$7.96M
11,610
0.0033%
$4.35M
+273.1%
Brosius Mark
EVP & Chief Mfg and Supply Cha
$5.75M (32) scheduled
−$5.75M
764
0.0002%
$286.07K
+36.9%
Jeddi Iman
SVP & GM da Vinci Platforms &
$2.37M (1) scheduled
−$2.37M
6,463
0.0018%
$2.42M
+10,854%
Miller Brian Edward
EVP & Chief Digital Officer
$2.01M (2) scheduled
−$2.01M
5,758
0.0016%
$2.16M
−40.5%
Widman Fredrik
VP Corporate Controller
$1.79M (7) scheduled
−$1.79M
1,026
0.0003%
$384.18K
+366.4%
BARRATT CRAIG H
Director
$1.64M (2) scheduled
−$1.64M
27,948
0.0079%
$10.46M
+6.9%
LOEB GARY
EVP & Chief Legal and Complian
$500.04K (3) scheduled
−$500.04K
5,320
0.0015%
$1.99M
+233.5%
Ladd Amy L
Director
$471.79K (4) scheduled
−$471.79K
179
<0.0001%
$67.02K
−78.2%
WADORS PATRICIA L
SVP Chief Human Resources Offi
$109.94K (1) scheduled
−$109.94K
0
0.0000%
$0.00
RUBASH MARK J
Director
16,790
0.0048%
$6.29M
+4.6%
Samath Jamie
EVP & CFO & Enterprise Technol
15,366
0.0043%
$5.75M
+73.3%
Johnson Amal M
Director
13,545
0.0038%
$5.07M
+10.3%
NACHTSHEIM JAMI K
Director
6,902
0.0020%
$2.58M
+22.5%
DeSantis Robert
EVP & Chief Strategy & Corp Op
5,224
0.0015%
$1.96M
−6.1%
Beery Joseph C
Director
3,641
0.0010%
$1.36M
+53.6%
Reed Monica P
Director
2,876
0.0008%
$1.08M
+79.1%
Kolli Sreelakshmi
Director
1,510
0.0004%
$565.40K
+529.2%
CHEW LEWIS
Director
1,314
0.0004%
$492.01K
+2,886%
Leonard Keith R
Director
901
0.0003%
$337.37K
−43.9%
Insider
Date
Role
Action
Shares
Price
Amount
Widman Fredrik
15 Sep 2026
VP Corporate Controller
Sold after exercise
543
$374.44
$203.32K
Widman Fredrik
15 Sep 2026
VP Corporate Controller
Sold after exercise
546
$374.44
$204.44K
Jeddi Iman
1 Jun 2026
SVP & GM da Vinci Platforms &
Sold after exercise
5,625
$420.55
$2.37M
Curet Myriam
10 Mar 2026
EVP & Chief Medical Officer
Sold after exercise
105
$493.95
$51.86K
Curet Myriam
2 Mar 2026
EVP & Chief Medical Officer
Sold after exercise indirect
125
$492.59
$61.57K
Curet Myriam
10 Feb 2026
EVP & Chief Medical Officer
Sold after exercise indirect
105
$494.65
$51.94K
Curet Myriam
29 Jan 2026
EVP & Chief Medical Officer
Sold after exercise
126
$520.02
$65.52K
GUTHART GARY S
27 Jan 2026
Director
Sold after exercise indirect
1,400
$531.52
$744.13K
GUTHART GARY S
27 Jan 2026
Director
Sold after exercise indirect
1,400
$531.53
$744.14K
GUTHART GARY S
27 Jan 2026
Director
Sold after exercise
24,500
$530.10
$12.99M
Curet Myriam
27 Jan 2026
EVP & Chief Medical Officer
Sold after exercise
125
$532.61
$66.58K
Curet Myriam
27 Jan 2026
EVP & Chief Medical Officer
Sold after exercise
105
$532.61
$55.92K
Brosius Mark
12 Dec 2025
SVP & Chief Mfg and Supply Cha
Sold after exercise
4,500
$547.36
$2.46M
Curet Myriam
10 Dec 2025
EVP & Chief Medical Officer
Sold after exercise
104
$559.90
$58.23K
GUTHART GARY S
1 Dec 2025
Executive Chair of the Board o
Sold after exercise
22,806
$570.89
$13.02M
Curet Myriam
1 Dec 2025
EVP & Chief Medical Officer
Sold after exercise
125
$568.99
$71.12K
BARRATT CRAIG H
12 Nov 2025
Director
Sold after exercise
750
$580.00
$435.00K
Charlton Henry L
12 Nov 2025
EVP & Chief Commercial and Mkt
Sold after exercise
4,731
$580.00
$2.74M
Charlton Henry L
12 Nov 2025
EVP & Chief Commercial and Mkt
Sold after exercise
2,901
$580.00
$1.68M
Charlton Henry L
12 Nov 2025
EVP & Chief Commercial and Mkt
Sold after exercise
2,898
$580.00
$1.68M
Charlton Henry L
12 Nov 2025
EVP & Chief Commercial and Mkt
Sold after exercise
2,565
$580.00
$1.49M
Charlton Henry L
12 Nov 2025
EVP & Chief Commercial and Mkt
Sold after exercise
636
$580.00
$368.88K
Miller Brian Edward
10 Nov 2025
EVP & Chief Digital Officer
Sold after exercise
2,202
$575.00
$1.27M
Miller Brian Edward
10 Nov 2025
EVP & Chief Digital Officer
Sold after exercise
1,298
$575.00
$746.35K
Curet Myriam
10 Nov 2025
EVP & Chief Medical Officer
Sold after exercise
105
$560.00
$58.80K
Widman Fredrik
5 Nov 2025
VP Corporate Controller
Sold after exercise
159
$550.00
$87.45K
Widman Fredrik
5 Nov 2025
VP Corporate Controller
Sold after exercise
1,908
$550.00
$1.05M
Curet Myriam
29 Oct 2025
EVP & Chief Medical Officer
Sold after exercise
125
$543.00
$67.88K
Curet Myriam
28 Oct 2025
EVP & Chief Medical Officer
Sold after exercise
1,379
$548.43
$756.28K
Curet Myriam
28 Oct 2025
EVP & Chief Medical Officer
Sold after exercise
1,153
$548.43
$632.33K
Curet Myriam
28 Oct 2025
EVP & Chief Medical Officer
Sold after exercise
5,030
$548.43
$2.76M
Rosa David J.
24 Oct 2025
Chief Executive Officer (CEO)
Sold after exercise
24,500
$547.55
$13.41M
BARRATT CRAIG H
24 Oct 2025
Director
Sold after exercise
2,193
$548.01
$1.20M
GUTHART GARY S
24 Oct 2025
Executive Chair of the Board o
Sold after exercise indirect
1,400
$546.18
$764.66K
GUTHART GARY S
24 Oct 2025
Executive Chair of the Board o
Sold after exercise indirect
1,400
$546.35
$764.89K
GUTHART GARY S
24 Oct 2025
Executive Chair of the Board o
Sold after exercise
28,800
$547.56
$15.77M

What was left out

Form 4 filings counted 89
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 46
Sales straight out of an exercise 36
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 398,656
History held since 28 Sep 2016